News Servier and Oncodesign announce Parkinson's R&D tie-up Servier and Oncodesign have announced a strategic partnership for R&D into potential drug candidates for Parkinson’s disease.
R&D LSX2026: On a therapeutic vision for ocular disease, with Al... Alexander Gebauer, co-founder & executive chairman of Galimedix Therapeutics, discusses transforming treatment of major neurodegenerative eye diseases
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
